NCT00274755View on ClinicalTrials.gov

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas

PHASE2CompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

April 30, 2007

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

chemotherapy

PROCEDURE

conventional surgery

PROCEDURE

magnetic resonance imaging

PROCEDURE

magnetic resonance spectroscopic imaging

RADIATION

radiation therapy

Trial Locations (1)

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT00274755 - Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas | Biotech Hunter | Biotech Hunter